These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32473917)

  • 21. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
    Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Role of the Podoplanin-CLEC-2 Axis in Promoting Inflammatory Response After Ischemic Stroke in Mice.
    Meng D; Ma X; Li H; Wu X; Cao Y; Miao Z; Zhang X
    Neurotox Res; 2021 Apr; 39(2):477-488. PubMed ID: 33165736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse podoplanin supports adhesion and aggregation of platelets under arterial shear: A novel mechanism of haemostasis.
    Lombard SE; Pollitt AY; Hughes CE; Di Y; Mckinnon T; O'callaghan CA; Watson SP
    Platelets; 2018 Nov; 29(7):716-722. PubMed ID: 29090616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis.
    Bourne JH; Beristain-Covarrubias N; Zuidscherwoude M; Campos J; Di Y; Garlick E; Colicchia M; Terry LV; Thomas SG; Brill A; Bayry J; Watson SP; Rayes J
    Front Immunol; 2021; 12():693974. PubMed ID: 34163489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.
    Lowe KL; Finney BA; Deppermann C; Hägerling R; Gazit SL; Frampton J; Buckley C; Camerer E; Nieswandt B; Kiefer F; Watson SP
    Blood; 2015 Jun; 125(24):3769-77. PubMed ID: 25908104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.
    Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L
    Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786
    [No Abstract]   [Full Text] [Related]  

  • 27. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.
    Payne H; Ponomaryov T; Watson SP; Brill A
    Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective Platelet Activation and Bleeding Complications upon Cholestasis in Mice.
    Gowert NS; Klier M; Reich M; Reusswig F; Donner L; Keitel V; Häussinger D; Elvers M
    Cell Physiol Biochem; 2017; 41(6):2133-2149. PubMed ID: 28441661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
    Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
    Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.
    Inoue O; Hokamura K; Shirai T; Osada M; Tsukiji N; Hatakeyama K; Umemura K; Asada Y; Suzuki-Inoue K; Ozaki Y
    PLoS One; 2015; 10(9):e0139357. PubMed ID: 26418160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
    Tanaka K; Tanaka M; Watanabe N; Ito M; Pastan I; Koizumi M; Matsusaka T
    Sci Rep; 2022 Dec; 12(1):22356. PubMed ID: 36572741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.
    Nagae M; Morita-Matsumoto K; Kato M; Kaneko MK; Kato Y; Yamaguchi Y
    Structure; 2014 Dec; 22(12):1711-1721. PubMed ID: 25458834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.
    Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M
    J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombomodulation via CLEC-2 targeting.
    O'Callaghan CA
    Curr Opin Pharmacol; 2009 Apr; 9(2):90-5. PubMed ID: 19091630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
    Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
    J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet CLEC-2 and podoplanin in cancer metastasis.
    Lowe KL; Navarro-Nunez L; Watson SP
    Thromb Res; 2012 Apr; 129 Suppl 1():S30-7. PubMed ID: 22682130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis.
    Rayes J; Lax S; Wichaiyo S; Watson SK; Di Y; Lombard S; Grygielska B; Smith SW; Skordilis K; Watson SP
    Nat Commun; 2017 Dec; 8(1):2239. PubMed ID: 29269852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The physiological and pathophysiological roles of platelet CLEC-2.
    Navarro-Núñez L; Langan SA; Nash GB; Watson SP
    Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.
    Joshi N; Kopec AK; O'Brien KM; Towery KL; Cline-Fedewa H; Williams KJ; Copple BL; Flick MJ; Luyendyk JP
    J Thromb Haemost; 2015 Jan; 13(1):57-71. PubMed ID: 25353084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CLEC-2 induced signalling in blood platelets].
    Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
    Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.